Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1 (2024)
Source: Organic Letters. Unidade: IQ
Subjects: COVID-19, ÁCIDOS NUCLEICOS, ADENOSINA TRIFOSFATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIJPKEMA, Koen J et al. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1. Organic Letters, v. 26, n. 27, p. 5700−5704, 2024Tradução . . Disponível em: https://dx.doi.org/10.1021/acs.orglett.4c01792. Acesso em: 18 nov. 2024.APA
Rijpkema, K. J., Schuller, M., Veer, M. S. van der, Rieken, S., Chang, D. L. R., Balić, P., et al. (2024). Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1. Organic Letters, 26( 27), 5700−5704. doi:10.1021/acs.orglett.4c01792NLM
Rijpkema KJ, Schuller M, Veer MS van der, Rieken S, Chang DLR, Balić P, Todorov A, Minnee H, Wijngaarden S, Matos IA, Hoch NC, Codée JDC, Ahel I, Filippov DV. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1 [Internet]. Organic Letters. 2024 ; 26( 27): 5700−5704.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1021/acs.orglett.4c01792Vancouver
Rijpkema KJ, Schuller M, Veer MS van der, Rieken S, Chang DLR, Balić P, Todorov A, Minnee H, Wijngaarden S, Matos IA, Hoch NC, Codée JDC, Ahel I, Filippov DV. Synthesis of structural ADP-ribose analogues as inhibitors for SARS-CoV-2 Macrodomain 1 [Internet]. Organic Letters. 2024 ; 26( 27): 5700−5704.[citado 2024 nov. 18 ] Available from: https://dx.doi.org/10.1021/acs.orglett.4c01792
